Letermovir noninferior for CMV prophylaxis in kidney recipients
Letermovir is noninferior to valganciclovir for prevention of cytomegalovirus (CMV) among CMV-seronegative kidney transplant recipients who receive an organ from a CMV-seropositive donor, according to a study published online ...
Jun 13, 2023
0
2
